Immune imitation of tumor progression after anti-CD19 chimeric antigen receptor T cells treatment in aggressive B-cell lymphoma
Ivetta Danylesko, Roni Shouval, Noga Shem‐Tov, Ronit Yerushalmi, Elad Jacoby, Michal J. Besser, Avichai Shimoni, Tima Davidson, Katia Beider, Dror Mevorach, Shalev Fried, Arnon Nagler, Abraham Avigdor
Topics & Concepts
MedicineChimeric antigen receptorLymphomaImmune systemTumor progressionInternal medicineOncologyImmunologyT cellCancer researchCancerCAR-T cell therapy researchCancer Immunotherapy and BiomarkersLymphoma Diagnosis and Treatment